Latest period
1.25B
YoY change
0.0%
5Y CAGR
-0.1%
Peak year (2007)
1.93B
Latest annual
1.25B
Shares Outstanding history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: 1.25B
Shares Outstanding growth chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: 0.0%
Shares Outstanding history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | 1.25B | 0.0% | 0 | ||
| 2024 | 1.25B | -0.2% | -3.00M | ||
| 2023 | 1.26B | -0.3% | -4.00M | ||
| 2022 | 1.26B | 0.0% | 0 | ||
| 2021 | 1.26B | -0.1% | -1.00M | ||
| 2020 | 1.26B | -1.1% | -14.00M | ||
| 2019 | 1.28B | -2.4% | -31.00M | ||
| 2018 | 1.31B | -0.8% | -11.00M | ||
| 2017 | 1.32B | -2.9% | -39.00M | ||
| 2016 | 1.36B | -10.7% | -163.00M | ||
| 2015 | 1.52B | -7.7% | -126.00M | ||
| 2014 | 1.65B | -2.8% | -47.75M | ||
| 2013 | 1.69B | +7.1% | +112.20M | ||
| 2012 | 1.58B | +0.1% | +2.31M | ||
| 2011 | 1.58B | -9.5% | -166.56M | ||
| 2010 | 1.75B | -6.5% | -121.43M | ||
| 2009 | 1.87B | -2.6% | -49.43M | ||
| 2008 | 1.92B | -0.6% | -11.06M | ||
| 2007 | 1.93B | +5.0% | +92.29M | ||
| 2006 | 1.84B | -3.2% | -60.71M | ||
| 2005 | 1.90B | +2.2% | +40.15M | ||
| 2004 | 1.86B | +15.4% | +248.14M | ||
| 2003 | 1.61B | -2.6% | -42.98M | ||
| 2002 | 1.65B | +2.1% | +33.25M | ||
| 2001 | 1.62B | +11.1% | +161.78M | ||
| 2000 | 1.46B | +6.3% | +86.36M | ||
| 1999 | 1.37B | +4.4% | +57.95M | ||
| 1998 | 1.31B | +26.2% | +272.48M | ||
| 1997 | 1.04B | +17.0% | +150.85M | ||
| 1996 | 889.15M | +30.6% | +208.38M | ||
| 1995 | 680.77M | +14.2% | +84.83M | ||
| 1994 | 595.94M | — | — | ||
| 1992 | 512.73M | +42.4% | +152.73M | ||
| 1991 | 360.00M | +18.1% | +55.24M | ||
| 1990 | 304.76M | — | — |
- 20251.25B0.0%
- 20241.25B-0.2%
- 20231.26B-0.3%
- 20221.26B0.0%
- 20211.26B-0.1%
- 20201.26B-1.1%
- 20191.28B-2.4%
- 20181.31B-0.8%
- 20171.32B-2.9%
- 20161.36B-10.7%
- 20151.52B-7.7%
- 20141.65B-2.8%
- 20131.69B+7.1%
- 20121.58B+0.1%
- 20111.58B-9.5%
- 20101.75B-6.5%
- 20091.87B-2.6%
- 20081.92B-0.6%
- 20071.93B+5.0%
- 20061.84B-3.2%
- 20051.90B+2.2%
- 20041.86B+15.4%
- 20031.61B-2.6%
- 20021.65B+2.1%
- 20011.62B+11.1%
- 20001.46B+6.3%
- 19991.37B+4.4%
- 19981.31B+26.2%
- 19971.04B+17.0%
- 1996889.15M+30.6%
- 1995680.77M+14.2%
- 1994595.94M—
- 1992512.73M+42.4%
- 1991360.00M+18.1%
- 1990304.76M—
Shares Outstanding values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported diluted shares outstanding is 1.25B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Gilead Sciences (GILD) reported diluted shares outstanding of 1.25B – edged up 0.0% year-over-year.
Across 2020–2025 (5 years), Gilead Sciences diluted shares outstanding produced a CAGR of -0.1% – with a net decline across the window.
Gilead Sciences diluted shares outstanding plunged from 1.93B in 2007 to 1.25B in 2025, a 34.9% drawdown.
Across the available history, diluted shares outstanding reached its high of 1.93B in 2007 and its low of 304.76M in 1990.
Gilead Sciences Shares Outstanding by Year
Gilead Sciences Shares Outstanding 2025: 1.25B
2025's diluted shares outstanding for Gilead Sciences came in at 1.25B, edged up 0.0% from 2024.
Gilead Sciences Shares Outstanding 2024: 1.25B
Gilead Sciences posted diluted shares outstanding of 1.25B in 2024, edged down 0.2% below 2023.
Gilead Sciences Shares Outstanding 2023: 1.26B
In 2023, Gilead Sciences reported diluted shares outstanding of 1.26B, edged down 0.3% below 2022.
Gilead Sciences Shares Outstanding 2022: 1.26B
Gilead Sciences diluted shares outstanding in 2022 was 1.26B, edged up 0.0% from 2021.
Gilead Sciences Shares Outstanding 2021: 1.26B
Gilead Sciences diluted shares outstanding in 2021 was 1.26B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Shares Outstanding
Healthcare peers of Gilead Sciences (GILD), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation